Profile data is unavailable for this security.
About the company
ADTRAN Holdings, Inc. is a provider of networking and communications platforms, software, and services focused on the broadband access market. The Company operates through two segments: Network Solutions segment, which includes hardware and software products, and Services & Support segment consists of a portfolio of maintenance, network installation and solution integration services, which include hosted cloud services and subscription services. The two segments span across Access & Aggregation, Subscriber Solutions & Experience and Traditional & Other Products. Its Access & Aggregation is focused on solutions that are used by service providers to connect their network infrastructure to subscribers. Its Subscriber Solutions & Experience is concentrated on subscriber solutions that terminate broadband access in the home and/or business. It also develops and provides networking solutions to network operators focusing on cloud access, cloud interconnection and network synchronization.
- Revenue in USD (TTM)618.80m
- Net income in USD-13.60m
- Incorporated2021
- Employees1.34k
- LocationADTRAN Holdings Inc901 Explorer BlvdHUNTSVILLE 35806United StatesUSA
- Phone+1 (256) 963-8220
- Fax+1 (302) 655-5049
- Websitehttps://acorn-offer.com/
More ▼
Mergers & acquisitions
| Acquired company | ADTN:NSQ since announced | Transaction value |
|---|---|---|
| ADVA Optical Networking SE | 1.06% | 1.03bn |
Data delayed at least 15 minutes, as of Aug 16 2022 21:00 BST.
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc | 6.41m | -369.42m | 1.50bn | 390.00 | -- | 1.38 | -- | 241.19 | -6.71 | -6.71 | 0.1163 | 20.51 | 0.0041 | -- | 1.03 | 16,446.15 | -23.63 | -38.82 | -24.48 | -43.42 | 87.93 | -- | -5,759.64 | -1,199.38 | 17.89 | -- | 0.0011 | -- | -- | -- | -8.26 | -- | -10.35 | -- |
| Sana Biotechnology Inc | 0.00 | -297.91m | 1.51bn | 461.00 | -- | 2.41 | -- | -- | -1.61 | -1.61 | 0.00 | 3.39 | 0.00 | -- | -- | 0.00 | -26.71 | -- | -28.49 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.75 | -- | -- | -- |
| Recursion Pharmaceuticals Inc | 12.95m | -211.74m | 1.52bn | 400.00 | -- | 3.42 | -- | 131.11 | -1.31 | -1.31 | 0.08 | 2.89 | 0.0257 | -- | 246.65 | 32,372.50 | -42.08 | -- | -47.39 | -- | -19.04 | -- | -1,635.19 | -- | -- | -81.01 | 0.0014 | -- | 156.89 | -- | -114.33 | -- | -- | -- |
| Pra Group Inc | 1.02bn | 145.21m | 1.53bn | 3.44k | 11.25 | 1.27 | 9.43 | 1.50 | 3.42 | 3.42 | 23.93 | 30.45 | 0.2442 | -- | 0.3121 | 295,850.60 | 3.52 | 3.13 | 3.70 | 3.28 | 79.99 | 82.67 | 14.40 | 12.89 | -- | 2.55 | 0.6763 | 0.00 | 2.85 | 3.32 | 22.65 | 16.25 | -4.56 | -- |
| Verve Therapeutics Inc | 0.00 | -125.20m | 1.62bn | 113.00 | -- | 5.25 | -- | -- | -2.58 | -2.58 | 0.00 | 6.08 | 0.00 | -- | -- | 0.00 | -33.35 | -- | -34.96 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -163.25 | -- | -- | -- |
| Monro Inc | 1.37bn | 57.88m | 1.65bn | 8.75k | 30.28 | 2.22 | 11.94 | 1.21 | 1.70 | 1.70 | 40.17 | 23.22 | 0.7375 | 6.00 | 100.25 | 156,233.70 | 3.15 | 3.82 | 3.87 | 4.51 | 34.97 | 37.14 | 4.27 | 4.98 | 0.3209 | 4.33 | 0.3895 | 50.66 | 20.75 | 5.88 | 80.33 | 0.0066 | -4.28 | 8.23 |
| Day One Biopharmaceuticals Inc | 0.00 | -105.46m | 1.67bn | 94.00 | -- | 4.43 | -- | -- | -1.77 | -1.77 | 0.00 | 5.32 | 0.00 | -- | -- | 0.00 | -29.27 | -- | -30.00 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -321.26 | -- | -- | -- |
| Taskus Inc | 913.95m | 50.05m | 1.73bn | 40.10k | 35.36 | 3.89 | 16.27 | 1.85 | 0.4888 | 0.4888 | 8.83 | 4.44 | 1.07 | -- | 5.93 | 22,791.75 | 5.84 | -- | 8.01 | -- | 42.59 | -- | 5.48 | -- | -- | 11.05 | 0.3797 | -- | 59.13 | -- | -269.98 | -- | -- | -- |
| Stagwell Inc | -100.00bn | -100.00bn | 1.79bn | 9.10k | -- | 5.37 | -- | -- | -- | -- | -- | 1.16 | -- | -- | -- | -- | -- | -1.29 | -- | -2.61 | -- | 34.22 | -- | -1.72 | -- | -- | 0.6037 | -- | 22.55 | 1.18 | 98.48 | -- | -5.12 | -- |
| Adtran Holdings Inc | 618.80m | -13.60m | 1.83bn | 1.34k | -- | 3.42 | 1,183.01 | 3.03 | -0.2801 | -0.2801 | 12.60 | 7.10 | 1.07 | 2.53 | 4.18 | 463,516.80 | -2.36 | -1.57 | -3.26 | -1.94 | 35.38 | 41.62 | -2.20 | -1.68 | 1.16 | -1.04 | -- | -- | 11.15 | -2.43 | -463.12 | -- | -23.36 | 0.00 |
| Alvotech SA | -100.00bn | -100.00bn | 1.83bn | 805.00 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -42.86 | -- | 40.31 | -- | -- | -- |
| Lyell Immunopharma Inc | 41.87m | -237.05m | 1.86bn | 219.00 | -- | 2.17 | -- | 45.16 | -0.9631 | -0.9631 | 0.1706 | 3.51 | 0.0372 | -- | -- | 191,191.80 | -21.06 | -- | -22.18 | -- | -- | -- | -566.14 | -- | -- | -- | 0.00 | -- | 37.31 | -- | -22.37 | -- | -- | -- |
| ICF International Inc | 1.62bn | 68.73m | 1.89bn | 8.00k | 27.90 | 2.31 | 18.06 | 1.17 | 3.61 | 3.61 | 84.86 | 43.54 | 0.9293 | -- | 4.04 | 210,210.80 | 3.95 | 4.40 | 4.95 | 5.69 | 36.50 | 36.19 | 4.25 | 4.25 | -- | 11.16 | 0.3545 | 13.99 | 3.06 | 5.56 | 29.43 | 8.83 | 7.64 | -- |
| Prometheus Biosciences Inc | 6.29m | -108.32m | 1.95bn | 72.00 | -- | 9.36 | -- | 308.57 | -2.78 | -2.78 | 0.1616 | 5.29 | 0.0219 | -- | 5.56 | 87,333.34 | -37.77 | -- | -39.57 | -- | -- | -- | -1,722.58 | -- | -- | -1,297.34 | 0.00 | -- | 154.60 | -- | -189.65 | -- | -- | -- |
| Frontdoor Inc | 1.65bn | 117.00m | 2.02bn | 2.08k | 18.53 | 347.68 | 13.82 | 1.27 | 1.38 | 1.38 | 19.68 | 0.0736 | 1.49 | -- | 122.07 | 791,926.90 | 10.58 | 10.49 | 16.92 | 16.65 | 45.45 | 48.35 | 7.10 | 9.61 | -- | 6.93 | 0.9904 | 0.00 | 8.68 | 9.45 | 14.29 | 0.637 | 23.03 | -- |
| Xpel Inc | 294.42m | 34.24m | 2.08bn | 709.00 | 65.31 | 21.70 | 54.72 | 7.60 | 1.24 | 1.24 | 10.66 | 3.73 | 2.00 | 3.70 | 18.55 | 415,253.90 | 23.26 | 25.68 | 29.90 | 35.22 | 37.31 | 33.13 | 11.63 | 10.14 | 0.8269 | 27.75 | 0.2378 | -- | 63.14 | 38.02 | 72.67 | 70.12 | 41.35 | -- |
Data as of Aug 16 2022. Currency figures normalised to ADTRAN Holdings Inc's reporting currency: US Dollar USD
57.37%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 30 Jun 2022 | 7.29m | 14.78% |
| The Vanguard Group, Inc.as of 30 Jun 2022 | 5.13m | 10.40% |
| DNB Asset Management ASas of 15 Jul 2022 | 2.47m | 5.01% |
| Newton Investment Management North America LLCas of 31 Mar 2022 | 2.43m | 4.92% |
| Dimensional Fund Advisors LPas of 30 Jun 2022 | 2.25m | 4.56% |
| Westwood Management Corp. (Texas)as of 31 Mar 2022 | 2.24m | 4.55% |
| Fuller & Thaler Asset Management, Inc.as of 30 Jun 2022 | 2.01m | 4.07% |
| SSgA Funds Management, Inc.as of 31 Mar 2022 | 1.64m | 3.33% |
| Bernzott Capital Advisorsas of 30 Jun 2022 | 1.61m | 3.26% |
| Schonfeld Strategic Advisors LLCas of 31 Mar 2022 | 1.24m | 2.51% |
More ▼
Data from 31 Mar 2022 - 30 Jun 2022Source: FactSet Research Systems Inc.
